DEVELOPMENT AND VALIDATION OF FIRST ORDER DERIVATIVE UV-SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN

Authors

  • Amrutiya Foram R Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610
  • Patel Bhumi R Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610
  • Patel Jaimin G Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610
  • Vegad Kunjal L Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610
  • Patel Amit S Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610
  • Dr. Darji Vinay C Department of Quality Assurance, Sharda School of Pharmacy, Pethapur, Gandhinagar, Gujarat, India-382610

Keywords:

Empagliflozin, Linagliptin, First derivative UV-spectrophotometric method, Method validation

Abstract

Simple and reliable first order derivative spectrophotometric method was developed and validated for the simultaneous estimation of empagliflozin and linagliptin in combined dosage form. The quantitative determination of the drugs was carried out using the first order derivative values measured at 221 nm and 238 nm for empagliflozin and linagliptin respectively. The solutions of standard and the sample were prepared in methanol. Calibration graphs constructed at their wavelengths of determination were linear in the concentration range of 2.5-30 ?g/ml for both empagliflozin and linagliptin. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed method. Developed first derivative spectrophotometric method was simple, accurate, precise, specific, sensitive and reproducible which can be directly and easily applied to pharmaceutical dosage forms.

Downloads

Download data is not yet available.

References

Drug profile for empagliflozin. 2016; www.drugbank.ca/drugs/DB09038.

Drug profile for empagliflozin. 2016; www.aksci.com/item_detail.php?cat=X5927.

Padmaja N, Veerabhadram G. Method development and validation of rp-hplc method for the estimation of empagliflozin in api. Int J Pharm and Pharm Sci. 2016; 7(2): 724-727.

Shyamala M, Soumika M, Sangeetha E, Mahender L. Method development and validation of empagliflozin by rp-hplc in bulk and pharmaceutical dosage form. Int J Adv in Pharm Sci. 2016; 7(1): 3040-3042.

Jyothirmai N, Nagaraju B, Anilkumar M. Novel uv and visible spectrophotometric methods for the analysis of empagliflozin a type 2 diabetic drug in bulk and pharmaceutical formulations, J de Afrikana. 2016; 3(1): 177-187.

Drug profile for linagliptin. 2016; www.drugbank.ca/drugs/DB08882

O’ Neil MJ. The Merck Index: An Encyclopedia of chemicals, drugs and biologicals, 15th ed. New Jersey: Published by Merck Research Laboratories, Division of Merck and Co., Inc. Whitehouse station: 1022, (2013).

Lakshman R. A validated rp-hplc method for the determination of linagliptin. Am J Pharm Tech Res. 2012; 2(4): 463-470.

Zubair M, Murali B, Rajesh G. Rp-hplc method development and validation of linagliptin in bulk drug and pharmaceutical dosage form. Der Pharm Sinica. 2014; 5(5): 123-130.

Vijayasri K, Anusha M Ravinder R. A rapid rp-hplc method development and validation for the analysis of linagliptin bulk and pharmaceutical dosage form. Asian J Pharm Anal. 2015; 5(1): 16-20.

Nidhi D, Anchal T, Rakesh B, Raghav C. Development and validation of ultra-performance liquid chromatography (up-lc) method for estimation of a new anti-diabetic drug linagliptin in bulk and its tablet formulation. Indian J Chem. 2014; 53(B): 1136-1139.

Sujan B, Palash K, Anowar H, Development and validation of a uv spectrophotometric method for determination of vildagliptin and linagliptin in bulk and pharmaceutical dosage forms. Ban Pharm J. 2015; 18(2): 163-168.

Sujan B, Masud K, Mohammad SH. Development and validation of a simple and rapid uv spectropho-tometer method for assay of linagliptin in bulk and marketed dosage form. Indian J of Novel Drug Delivery. 2013; 5(4): 221-224.

Chandra K, Sudhakar P, Mohanrao T, Vijayababu P, Manikanta K, A new uv-method for determination of linagliptin in bulk and pharmaceutical dosage form. Int J of Universal Pharm and Bio Sci. 2013; 2(4): 1-6.

Madhusudhan P, Radhakrishna R. Devanna N. Rp-hplc method development and validation for simultaneous determination of linagliptin and empagliflozin in tablet dosage form. Int Adv Res J Sci Eng and Tech. 2015; 2(2): 95-99.

Padmaja N, Veerabhadram G. Development and validation of analytical method for simultaneous estimation of empagliflozin and linagliptin in bulk drugs and combined dosage forms using uv-visible spectroscopy. Der Pharmacia Lettre. 2015; 7(12): 306-312.

The International conference on harmonization, Q2 (R1), Validation of Analytical Procedure: Text and Methodology: 2005.

Published

2017-04-25
Statistics
127 Views | 56 Downloads
Citatons

How to Cite

Amrutiya Foram R, Patel Bhumi R, Patel Jaimin G, Vegad Kunjal L, Patel Amit S, and Dr. Darji Vinay C. “DEVELOPMENT AND VALIDATION OF FIRST ORDER DERIVATIVE UV-SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN ”. International Journal of Pharmaceutics and Drug Analysis, vol. 5, no. 4, Apr. 2017, pp. 129-35, https://ijpda.com/index.php/journal/article/view/279.

Issue

Section

Research Articles
Share |